Table 3 Meta-analytic pooled results of survival based on the RFA versus SR
From: Sublobar resection versus ablation for stage I non-small-cell lung cancer: a meta-analysis
Number of studies | HR (95% CI) | Heterogeneity | Favor | |
|---|---|---|---|---|
Overall survival | 5 | 1.24 (1.11, 1.38), P = 0.0002 | I2 = 77% | SR |
Progression-free survival | 5 | 1.30 (1.11, 1.51), P = 0.001 | I2 = 75% | SR |
Cancer-specific survival | 4 | 1.33 (1.09, 1.62), P = 0.005 | I2 = 73% | SR |